Capabilities of Molecular Genetic Methods for Effective Hereditary Cancers Detection in Individuals with High Cancer Risk Factors

Russia and other countries report an increase in the incidence of malignant neoplasms, and approximately 10 % of all oncological cases have hereditary background. Molecular genetic testing in patients with diagnosed malignant neoplasms and a suspected hereditary factor will help to select effective modern methods of treatment and prevention of the development of neoplasms of other localizations.
According to the study, 12,6 % of patients had hereditary cancer syndrome, which allowed to administer molecular genetic tests to patients’ relatives. Consequently, it becomes possible to detect hereditary cancer risk factors, improve the efficiency of clinical examination, elaborate and implement programs for prevention and early detection of the disease.

1. Kaprin A.D., Starinsky V.V., Shakhzadova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost’ i smertnost’) [Malignant neoplasms in Russia in 2021 (morbidity and mortality)], Moscow, Herzen Moscow Oncology Research Institute – branch of the Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of the Russian Federation Publ., 2022, 252 p. (in Russian).

2. Rak [Cancer]. World Health Organization, URL: https://www.who.int/ru/news-room/fact-sheets/detail/ cancer (date of the application: 30.04.2023) (in Russian).

3. Garber J., Offit K. Hereditary cancer predisposition syndromes. J clin oncol, 2005, vol. 23, no. 2, pp. 276-292. doi: 10.1200/jco.2005.10.042.

4. Hemminki K., Sundquist J., Bermejo J. How common is familial cancer? Annals of oncology, 2008, vol. 19, no. 1, pp. 163-167. doi: 10.1093/annonc/mdm414.

5. Baranova E. E., Bodunova N. A., Vorontsova M. V., Zakharova G. S., Makarova M. V., Rumyantsev P. O., Khatkov I. E. Hereditary tumor syndromes: a modern paradigm. Problems of endocrinology, 2020, vol. 66, no. 4, pp. 24-34. doi: 10.14341/probl12366 (in Russian).

6. Khatkov I. E., Movsesyan G. V., Lisitsa T. S., Litvinova M. M., Bodunov N.A. The role of medical genetic counseling for patients with familial cancer. Evidence-based gastroenterology, 2019, vol. 8, no. 1, iss. 3, pp. 56-57 (in Russian).

7. Shahi R., De Brakeleer S., Caljon B., Pauwels I., Bonduelle M., Joris S., Fontaine Ch., Vanhoeij M., Van Dooren S., Teugels E., De Grève J. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. BMC cancer, 2019, vol. 19, no. 1, pp. 313. doi: 10.1186/s12885-019-5494-7.

8. Pieterse A., Van Dulmen A., Beemer F., Bensing J., Ausems M. Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment. J genet couns, 2007, vol. 16, no. 1, pp. 85-96. doi:10.1007/s10897-006-9048-1.

9. Aksenova I. A. et al. Metodicheskie rekomendatsii po organizatsii tsentrov ambulatornoj onkologicheskoj pomoshchi v sub”ektah Rossijskoj Federatsii [Guidelines for the organization of outpatient cancer care centers in the constituent entities of the Russian Federation], Moscow, 2021 (in Russian).

10. Starodubov V. I. et al. Itogi dispanserizatsii opredelennyh grupp vzroslogo naseleniya Rossijskoj Federatsii 2013–2018 gg.: informatsionno-analiticheskij obzor [The results of medical examination of certain groups of the adult population of the Russian Federation in 2013–2018: information and analytical review], Moscow, RIO TsNIIOIZ of the Ministry of Health of the Russian Federation Publ., 2019, 114 p. (in Russian).

11. Aleksandrova L. M., Gretsova O. P., Petrova G. V., Starinsky V. V., Kaprin A. D., Kalinina A. M., Ipatov P. V., Bojtsov S. A. Detection of malignant neoplasms of the mammary gland and organs of the female reproductive system during clinical examination of certain groups of the adult population. Preventive medicine, 2016, vol. 19, no. 3, pp. 4-11 (in Russian).

12. Online Mendelian Inheritance in Man (OMIM). Omim.org, URL: https://www.omim.org/ (date of the application: 30.04.2023).

13. The Genome Aggregation Database. GnomAD, URL: https://gnomad.broadinstitute.org/ (date of the application: 30.04.2023).

14. ACMG (American College of Medical Genetics and Genomics). URL: https://www.acmg.net/ (date of the application: 30.04.2023).

15. Ryzhkova O. P., Kardymon O. L., Prokhorchuk E. B., Konovalov F. A., Maslennikov A. B., Stepanov V. A., Afanasiev A. A., Zaklyazminskaya E. V., Rebrikov D. V., Savostyanov K. V., Glotov A. S., Kostareva A. A., Pavlov A. E., Golubenko M. V., Polyakov A. V., Kutsev S. I. Guidelines for the interpretation of human DNA sequence data obtained by massive parallel sequencing (MPS) methods (edition 2018, version 2). Medical genetics, 2019, vol. 18, no. 2, pp. 3-23. doi: 10.25557/2073-7998.2019.02.3-23 (in Russian).

16. Novikova E. I., Kudinova V. K., Bozhenko V. K., Solodkiy V. A. Characteristics of BRCA-associated breast cancer in the Russian population. Vestnik RSMU, 2021, no. 1, pp. 26-32 (in Russian).

17. Espinel W., Champine M., Hampel H., Jeter J., Sweet K., Pilarski R., Pearlman R., Shane K., Brock P., Westman J., Kipnis L., Sotelo J., Chittenden A., Culver S., Stopfer J., Schneider K., Sacca R., Koeller D., Gaonkar Sh., Vaccari E., Kane S., Michalski S., Yang Sh., Nielsen S., Bristow S., Lincoln S., Nussbaum R., Esplin E. Clinical impact of pathogenic variants in DNA damage repair genes beyond BRCA1 and BRCA2 in breast and ovarian cancer patients. Cancers, 2022, vol. 14, no. 10, pp. 2426. doi: 10.3390/cancers14102426.

18. Slavin T., Niell-Swiller M., Solomon I., Nehoray B., Rybak Ch., Blazer K., Weitzel J. Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management. Front oncol, 2015, vol. 5, p. 208. doi: 10.3389/fonc.2015.00208.

19. Rekomendatsii po meditsinskomu soprovozhdeniyu patsientov s verifitsirovannymi (podtverzhdennymi) nasledstvennymi opuholevymi sindromami i ih rodstvennikov s vyyavlennoj predraspolozhennost’yu k razvitiyu onkologicheskih zabolevanij: metodicheskie rekomendatsii [Recommendations for medical support of patients with verified (confirmed) hereditary tumor syndromes and their relatives with an identified predisposition to the development of oncological diseases: guidelines], Moscow Healthcare Department, URL: https://mosgenetics.ru/2022/12/23/gallery-post-format/ (date of the application: 30.04.2023) (in Russian).